$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
on January 9, 2023
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:17 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
on January 9, 2023
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:17 PM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on December 9, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:01 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on December 9, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:01 PM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces Presentations and Investor Event at American Epilepsy Society 2022 Annual Meeting
on November 30, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:01 PM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on November 18, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on November 18, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:00 AM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces Pricing of $60 Million Public Offering
on November 8, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
9:12 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Proposed Public Offering
on November 7, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
2:23 PM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners
on October 31, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
5:30 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces $32.5 Million Revenue Interest Financing Agreement with Sagard Healthcare Partners
on October 31, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
5:30 AM
Symbol:
MRNS
Source:
$MRNS Marinus Pharmaceuticals Announces Multiple Presentations at Upcoming Medical Meetings
on October 11, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Exercise of First Contract Option by the Biomedical Advanced Research and Development Authority (BARDA)
on September 22, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on September 9, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
4:05 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals to Present at Upcoming Investor Conferences
on September 7, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Closing of Sale of Priority Review Voucher for $110 Million
on August 29, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on August 12, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
8:00 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on July 15, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
4:05 PM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Expands Enrollment Criteria to Support Recruitment in Phase 3 RAISE Trial in Refractory Status Epilepticus
on June 8, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
7:30 AM
Symbol:
MRNS
Source:
Business Wire
$MRNS Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
on June 3, 2022
News
and Tags: Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals Inc. News, MRNS, MRNS News
with 0 comments
Time:
4:01 PM
Symbol:
MRNS
Source:
Business Wire